Root Financial Partners
ALNY icon

Root Financial Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Root Financial Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.1K Buy
+195
New +$49.6K ﹤0.01% 1110
2026
Q2 		– Sell
-79
Closed -$26.1K – 515
2026
Q1 		$26.1K Buy
79
+17
+27% +$5.78K ﹤0.01% 1176
2025
Q4 		$24.7K Buy
62
+8
+15% +$3.54K ﹤0.01% 1071
2025
Q3 		$24.6K Buy
+54
New +$22K ﹤0.01% 1007

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Root Financial Partners's ALNY Position: Q3 2026 in Review

Root Financial Partners opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 195 shares worth $48.1K. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ALNY as recently as Q1 2026.

Root Financial Partners first reported a position in ALNY in Q3 2025 and has held it in 4 quarters since. 403 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Root Financial Partners held 195 shares of Alnylam Pharmaceuticals worth $48.1K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1110 holding.
  • Root Financial Partners first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 403 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.